Sciensus
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus announced a leadership change on October 28, 2026. Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
What changed
James Tugendhat was named Chief Executive Officer. Gordon Cox led the business as interim CEO during the Board’s search for a new CEO and continues as Chief Operating Officer and as a member of key company boards.
- Leader: James Tugendhat
- Role: Chief Executive Officer
- Effective: Not specified in the announcement
- Announcement date: October 28, 2026
Leadership background
Tugendhat brings more than 20 years of leadership experience across healthcare and complex service organisations, the company said. He was most recently Group CEO of HC-One, which the release describes as the UK’s largest care home operator, and previously held senior roles at Bupa, including CEO of Health Dialog, a US health analytics and chronic disease management company. He also served for seven years as a non-executive director of the Royal Free London NHS Foundation Trust.
The mandate
Tugendhat said he is looking forward to working with colleagues across the business, building on the deep expertise already in place to support patients, healthcare providers and Sciensus’s biotech and pharmaceutical partners.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: Sciensus leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Coherix Names Ed Allen Chief Executive Officer
Coherix named board member Ed Allen chief executive officer, succeeding Dwight Carlson, who will continue as chairman; the company said it will focus on expanding its global customer base across automotive, battery manufacturing, and consumer electronics.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started